Analytical Validation of Cofactor Genomics’ Immune Profiling Assay Published in Journal of Molecular Diagnostics
SAN FRANCISCO, Calif. – April 16, 2020 – Today, Cofactor Genomics announced the peer-reviewed publication of an analytical validation study demonstrating the performance of its novel RNA-based immune profiling assay, ImmunoPrism®, in the April 2020 issue of the Journal of Mole...
ImmunoPrism Protocol Published in Peer-Reviewed Journal of Visualized Experiments
Cambridge, MA – March 10, 2020 – Video methods for the molecular protocol associated with the Cofactor Genomics ImmunoPrism® Assay are now published in the Journal of Visualized Experiments. The peer-reviewed publication, entitled “Predictive Immune Modeling of Solid Tumors,” ...
New Study Shows Predictive Immune Modeling from Cofactor Genomics is Superior to PD-L1 Assays in Predicting Patient Response to Anti-PD-1 Therapy
SCOTTSDALE, Ariz. -- February 27, 2020 -- Cofactor Genomics, the company bridging the precision medicine gap with Predictive Immune Modeling, today announced preliminary results from a collaborative study with Washington University School of Medicine in St. Louis, which demons...